Literature DB >> 33393318

Risk factors for mortality of 557 adult patients with COVID 19 in Babol, Northern Iran: a retrospective cohort study.

M Javanian, M Bayani, M Shokri, M Sadeghi-Haddad-Zavareh, A Babazadeh, R Ghadimi, M Sepidarkish, A Bijani, Y Yahyapour, M Barary, A H Hasanpour, S Ebrahimpour.   

Abstract

BACKGROUND: This study was aimed to investigate the risk factors for mortality in patients with COVID-19.
METHODS: For this retrospective cohort study, we included 121 deceased and 436 discharged cases with COVID-19 in Babol, Northern Iran. The cases were between March 1 to April 1, 2020.
RESULTS: Multivariate Poisson regression analysis revealed that older age (aRR: 1.03, 95% CI: 1.01, 1.05, p < 0.001), hospital length of stay (aRR: 0.94, 95% CI: 0.90, 0.97, p = 0.003), ICU admission (aRR: 4.34, 95% CI: 2.95, 6.37, p < 0.001), cerebrovascular disease (aRR: 1.96, 95% CI: 1.20, 3.19, p = 0.007), ventilator-associated pneumonia (VAP) (aRR: 2.09, 95% CI: 1.22, 3.55, p = 0.006), septic shock (aRR: 2.98, 95% CI: 1.44, 6.19, p = 0.003), acute respiratory distress syndrome (ARDS) (aRR: 3.80, 95% CI: 2.28, 6.31, p < 0.001), acute kidney failure (AKF) (aRR: 1.45, 95% CI: 1.12, 3.76, p = 0.021), acute heart failure (AHF) (aRR: 1.63, 95% CI: 1.01, 2.62, p = 0.043) and lymphocyte count (aRR: 3.01, 95% CI: 1.99, 4.57, p < 0.001) were associated with mortality.
CONCLUSION: Findings showed that elderly with comorbidities such as cerebrovascular diseases had an increased risk of death. Some complications such as: pneumonia, septic shock, ARDS, AHF, and AKF played crucial roles as well death (Tab. 2, Ref. 25).

Entities:  

Keywords:  COVID-19; clinical characteristics laboratory findings.; mortality

Year:  2021        PMID: 33393318     DOI: 10.4149/BLL_2021_003

Source DB:  PubMed          Journal:  Bratisl Lek Listy        ISSN: 0006-9248            Impact factor:   1.278


  6 in total

Review 1.  Breakthrough SARS-CoV-2 infections after vaccination: a critical review.

Authors:  Zeinab Mohseni Afshar; Mohammad Barary; Rezvan Hosseinzadeh; Amirmasoud Alijanpour; Dariush Hosseinzadeh; Soheil Ebrahimpour; Kosar Nazary; Terence T Sio; Mark J M Sullman; Kristin Carson-Chahhoud; Arefeh Babazadeh
Journal:  Hum Vaccin Immunother       Date:  2022-03-18       Impact factor: 4.526

Review 2.  Coronavirus disease 2019 (Covid-19) vaccination recommendations in special populations and patients with existing comorbidities.

Authors:  Zeinab Mohseni Afshar; Arefeh Babazadeh; Alireza Janbakhsh; Feizollah Mansouri; Terence T Sio; Mark J M Sullman; Kristin Carson-Chahhoud; Rezvan Hosseinzadeh; Mohammad Barary; Soheil Ebrahimpour
Journal:  Rev Med Virol       Date:  2021-10-22       Impact factor: 11.043

Review 3.  COVID-19 vaccination challenges: A mini-review.

Authors:  Zeinab Mohseni Afshar; Mohammad Barary; Rezvan Hosseinzadeh; Bardia Karim; Soheil Ebrahimpour; Kosar Nazary; Terence T Sio; Mark J M Sullman; Kristin Carson-Chahhoud; Emaduddin Moudi; Arefeh Babazadeh
Journal:  Hum Vaccin Immunother       Date:  2022-05-05       Impact factor: 4.526

4.  Application of machine learning models based on decision trees in classifying the factors affecting mortality of COVID-19 patients in Hamadan, Iran.

Authors:  Samad Moslehi; Niloofar Rabiei; Ali Reza Soltanian; Mojgan Mamani
Journal:  BMC Med Inform Decis Mak       Date:  2022-07-24       Impact factor: 3.298

Review 5.  The role of cytokines and their antagonists in the treatment of COVID-19 patients.

Authors:  Zeinab Mohseni Afshar; Mohammad Barary; Arefeh Babazadeh; Ali Tavakoli Pirzaman; Rezvan Hosseinzadeh; Amirmasoud Alijanpour; Amirreza Allahgholipour; Seyed Rouhollah Miri; Terence T Sio; Mark J M Sullman; Kristin Carson-Chahhoud; Soheil Ebrahimpour
Journal:  Rev Med Virol       Date:  2022-05-27       Impact factor: 11.043

Review 6.  Challenges posed by COVID-19 in cancer patients: A narrative review.

Authors:  Zeinab Mohseni Afshar; Rezvan Hosseinzadeh; Mohammad Barary; Soheil Ebrahimpour; Amirmasoud Alijanpour; Babak Sayad; Dariush Hosseinzadeh; Seyed Rouhollah Miri; Terence T Sio; Mark J M Sullman; Kristin Carson-Chahhoud; Arefeh Babazadeh
Journal:  Cancer Med       Date:  2021-12-23       Impact factor: 4.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.